5/30/2013

The American College of Obstetricians and Gynecologists issued a committee opinion advising against the use of menopausal hormone therapy for primary or secondary prevention of coronary heart disease. The group said there is not enough evidence linking long-term estrogen treatment or hormone therapy to improved cardiovascular outcomes. "As with younger women, use of hormone therapy and estrogen therapy should be individualized based on each woman's risk-benefit ratio and clinical presentation," ACOG said in the journal Obstetrics & Gynecology.

Related Summaries